Phase 2 study of anastrozole in rare cohorts of patients with estrogen receptor/progesterone receptor positive leiomyosarcomas and carcinosarcomas of the uterine corpus: The PARAGON trial (ANZGOG 0903)
Richard J. Edmondson, Rachel O’Connell, Susana Banerjee, Linda Mileshkin, Peter Sykes, Philip Beale, Ann D Fisher, Anthony Bonaventura, David Millan, Steven Nottley, Charlotte Benson, Anne Hamilton, Katrin Marie Sjoquist, Laura E. Crotty Alexander, Caroline Kelly, Karen Carty, Laura Divers, Nathan Bradshaw, Michael Friedländer
Topics & Concepts
MedicineAnastrozoleInternal medicineClinical endpointProgression-free survivalProgressive diseaseClinical trialGynecologyOncologyGastroenterologyDiseaseChemotherapyCancerTamoxifenBreast cancerUterine Myomas and TreatmentsEndometrial and Cervical Cancer TreatmentsSarcoma Diagnosis and Treatment